Pelvic inflammatory disease: Metaanalysis of antimicrobial regimen efficacy

Cheryl K. Walker, James G. Kahn, A. Eugene Washington, Herbert B. Peterson, Richard L Sweet

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

An extensive body of literature has investigated the efficacy of antimicrobial regimens used to treat pelvic inflammatory disease (PID), leaving many clinicians confused about how to choose among them. This study provides a formal appraisal of these reports. Thirty-four treatment studies published between 1966 and 1992 were identified, using Medline and bibliographies, and evaluated qualitatively and quantitatively in a metaanalysis. Twenty-one studies met the criteria for inclusion in this evaluation: appropriate system for making the diagnosis of PID, standardized assessment of clinical outcome, and entry and follow-up evaluation for lower genital tract infection with Neisseria gonorrhoeae and Chlamydia trachomatis. This metaanalysis identifies a considerable range of quality in study methods and research design and underscores the limitations inherent in comparing such data. Despite this, a number of antimicrobial regimens appear to have very good short-term clinical and microbiologic efficacy. Pooled clinical cure rates range from 75% to 94% and pooled microbiologic cure rates range from 71% to 100%. A cost comparison is provided, and future research priorities are suggested.

Original languageEnglish (US)
Pages (from-to)969-978
Number of pages10
JournalJournal of Infectious Diseases
Volume168
Issue number4
StatePublished - Oct 1993

Fingerprint

Pelvic Inflammatory Disease
Reproductive Tract Infections
Neisseria gonorrhoeae
Chlamydia trachomatis
Bibliography
Research Design
Outcome Assessment (Health Care)
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Walker, C. K., Kahn, J. G., Washington, A. E., Peterson, H. B., & Sweet, R. L. (1993). Pelvic inflammatory disease: Metaanalysis of antimicrobial regimen efficacy. Journal of Infectious Diseases, 168(4), 969-978.

Pelvic inflammatory disease : Metaanalysis of antimicrobial regimen efficacy. / Walker, Cheryl K.; Kahn, James G.; Washington, A. Eugene; Peterson, Herbert B.; Sweet, Richard L.

In: Journal of Infectious Diseases, Vol. 168, No. 4, 10.1993, p. 969-978.

Research output: Contribution to journalArticle

Walker, CK, Kahn, JG, Washington, AE, Peterson, HB & Sweet, RL 1993, 'Pelvic inflammatory disease: Metaanalysis of antimicrobial regimen efficacy', Journal of Infectious Diseases, vol. 168, no. 4, pp. 969-978.
Walker, Cheryl K. ; Kahn, James G. ; Washington, A. Eugene ; Peterson, Herbert B. ; Sweet, Richard L. / Pelvic inflammatory disease : Metaanalysis of antimicrobial regimen efficacy. In: Journal of Infectious Diseases. 1993 ; Vol. 168, No. 4. pp. 969-978.
@article{9dc5c6596eaa4fe188aa8d5974d0647d,
title = "Pelvic inflammatory disease: Metaanalysis of antimicrobial regimen efficacy",
abstract = "An extensive body of literature has investigated the efficacy of antimicrobial regimens used to treat pelvic inflammatory disease (PID), leaving many clinicians confused about how to choose among them. This study provides a formal appraisal of these reports. Thirty-four treatment studies published between 1966 and 1992 were identified, using Medline and bibliographies, and evaluated qualitatively and quantitatively in a metaanalysis. Twenty-one studies met the criteria for inclusion in this evaluation: appropriate system for making the diagnosis of PID, standardized assessment of clinical outcome, and entry and follow-up evaluation for lower genital tract infection with Neisseria gonorrhoeae and Chlamydia trachomatis. This metaanalysis identifies a considerable range of quality in study methods and research design and underscores the limitations inherent in comparing such data. Despite this, a number of antimicrobial regimens appear to have very good short-term clinical and microbiologic efficacy. Pooled clinical cure rates range from 75{\%} to 94{\%} and pooled microbiologic cure rates range from 71{\%} to 100{\%}. A cost comparison is provided, and future research priorities are suggested.",
author = "Walker, {Cheryl K.} and Kahn, {James G.} and Washington, {A. Eugene} and Peterson, {Herbert B.} and Sweet, {Richard L}",
year = "1993",
month = "10",
language = "English (US)",
volume = "168",
pages = "969--978",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Pelvic inflammatory disease

T2 - Metaanalysis of antimicrobial regimen efficacy

AU - Walker, Cheryl K.

AU - Kahn, James G.

AU - Washington, A. Eugene

AU - Peterson, Herbert B.

AU - Sweet, Richard L

PY - 1993/10

Y1 - 1993/10

N2 - An extensive body of literature has investigated the efficacy of antimicrobial regimens used to treat pelvic inflammatory disease (PID), leaving many clinicians confused about how to choose among them. This study provides a formal appraisal of these reports. Thirty-four treatment studies published between 1966 and 1992 were identified, using Medline and bibliographies, and evaluated qualitatively and quantitatively in a metaanalysis. Twenty-one studies met the criteria for inclusion in this evaluation: appropriate system for making the diagnosis of PID, standardized assessment of clinical outcome, and entry and follow-up evaluation for lower genital tract infection with Neisseria gonorrhoeae and Chlamydia trachomatis. This metaanalysis identifies a considerable range of quality in study methods and research design and underscores the limitations inherent in comparing such data. Despite this, a number of antimicrobial regimens appear to have very good short-term clinical and microbiologic efficacy. Pooled clinical cure rates range from 75% to 94% and pooled microbiologic cure rates range from 71% to 100%. A cost comparison is provided, and future research priorities are suggested.

AB - An extensive body of literature has investigated the efficacy of antimicrobial regimens used to treat pelvic inflammatory disease (PID), leaving many clinicians confused about how to choose among them. This study provides a formal appraisal of these reports. Thirty-four treatment studies published between 1966 and 1992 were identified, using Medline and bibliographies, and evaluated qualitatively and quantitatively in a metaanalysis. Twenty-one studies met the criteria for inclusion in this evaluation: appropriate system for making the diagnosis of PID, standardized assessment of clinical outcome, and entry and follow-up evaluation for lower genital tract infection with Neisseria gonorrhoeae and Chlamydia trachomatis. This metaanalysis identifies a considerable range of quality in study methods and research design and underscores the limitations inherent in comparing such data. Despite this, a number of antimicrobial regimens appear to have very good short-term clinical and microbiologic efficacy. Pooled clinical cure rates range from 75% to 94% and pooled microbiologic cure rates range from 71% to 100%. A cost comparison is provided, and future research priorities are suggested.

UR - http://www.scopus.com/inward/record.url?scp=0027328970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027328970&partnerID=8YFLogxK

M3 - Article

C2 - 8376843

AN - SCOPUS:0027328970

VL - 168

SP - 969

EP - 978

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -